Extrait

Percentage of patients developing no skin toxicity ≥ grade 2 at any time during their first 8-weeks of treatment with panitumumab

Critère d'inclusion

• Panitumumab-mediated Skin toxicity in palliative treatment of Metastatic colorectal cancer with panitumumab

Liens

• ictrp
• euctr